Sources Listing Archive
Archived Listing - Last Updated: December 2008. This information represents a historical archive of listings which appeared in SOURCES, which has been continuously published in print and online since 1977. The information has not been updated since the date indicated. For current information consult the SOURCES website at www.sources.com. To be included in the current SOURCES listings, and to take advantage of other tools including unlimited news releases and event calendar postings, fill out the online membership form. For more information, see Frequently Asked Questions or call 416-964-7799.

Find Experts & Sources
Media coverage for your story
AEterna Zentaris Inc.
AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization.
The company's two lead compounds, Cetrorelix and AEZS-108, have reached advanced and late-stage clinical development. Cetrorelix is in an ongoing Phase 3 program in benign prostatic hyperplasia (BPH) while AEZS-108 is in a Phase 2 trial for endometrial and ovarian cancer.
(TSX: AEZ; NASDAQ: AEZS)

Areas of Expertise:


For information or updates contact Sources at 416-964-7799 or see our current publications and services online:

The Sources Directory     Include yourself in Sources     Media Names & Numbers

Sources Calendar     News Releases     Parliamentary Names & Numbers

© Sources 1977-2012. The information provided is copyright and may not be reproduced in any form or by any means (whether electronic, mechanical or photographic), or stored in an electronic retrieval system, without written permission of the publisher. The content may not be resold, republished, or redistributed. Indexing and search applications by Ulli Diemer and Chris DeFreitas.